Therapeutic Goods (Permissible Ingredients—Information that Must Accompany Application for Variation) Determination 2023
1Therapeutic Goods (Permissible Ingredients—Information that Must Accompany Application for Variation) Determination 2023
Start here
Get a plain-English read of 1
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Permissible Ingredients—Information that Must Accompany Application for Variation) Determination 2023.
meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 22.10.0
?xml version="1.0" encoding="utf-8" standalone="no"?>
Commonwealth Coat of Arms of Australia
Therapeutic Goods (Permissible Ingredients—Information that Must Accompany Application for Variation) Determination 2023
I, Nicholas Henderson, as delegate of the Secretary of the Department of Health and Aged Care, make the following determination.
Dated 24 January 2023
Nicholas Henderson
Acting First Assistant Secretary Medicines Regulation Division Health Products Regulation Group Department of Health and Aged Care
Contents
1 Name
2 Commencement
3 Authority
4 Definitions
5 Kind of information
6 Form of information
1 Name
This instrument is the Therapeutic Goods (Permissible Ingredients—Information that Must Accompany Application for Variation) Determination 2023.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
- Commencement information
- Column 1 Column 2 Column 3
- Provisions Commencement Date/Details
-
- The whole of this instrument 1 February 2023. 1 February 2023
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under subsections 26BD(8) and (9) of the Therapeutic Goods Act 1989.
4 Definitions
Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
(a) Secretary.
In this instrument:
Act means the Therapeutic Goods Act 1989.